Two foreign nationals employed by the National Institutes of Health were charged Tuesday with smuggling monkeypox into the United States from the Republic of Congo and lying to federal investigators, according to the U.S. Attorney's Office for the Eastern District of Michigan.
Vincent Munster, 53, a Dutch citizen who serves as chief of the Virus Ecology Section at the NIH's Rocky Mountain Laboratories in Montana, and Claude Kwe, 38, a Cameroonian national and NIH research fellow, were charged with conspiracy to smuggle monkeypox virus into the United States and making false statements to federal authorities. Both men work at a Biosafety Level 4 laboratory, the highest level of biological containment used for studying dangerous pathogens.
Federal prosecutors allege the pair arrived at Detroit Metropolitan Airport on January 25 after traveling from Brazzaville, Republic of Congo, where a monkeypox outbreak was ongoing. Customs and Border Protection officers questioned the men after noticing they were transporting a large black plastic case. Munster and Kwe told officers the case contained diagnostic and testing equipment.
Authorities later determined the case allegedly contained 113 biological vials packed inside Styrofoam coolers. Testing conducted on 20 of the vials found that 17 contained deactivated monkeypox virus, one contained chickenpox virus, and two contained human DNA.
"These NIH experts apparently broke our laws by smuggling viral pathogens on a packed commercial airplane from an outbreak in the Republic of Congo. Let that sink in," U.S. Attorney Jerome F. Gorgon Jr. said in a statement. Both men face a maximum sentence of five years in prison if convicted on all charges.
What the Left Is Saying
Democratic lawmakers and public health advocates have expressed concern about the security implications of the alleged smuggling, calling for enhanced vetting procedures for researchers with access to high-containment laboratories. Senate Health Committee Chair Bernard Sanders of Vermont said the charges highlight the need for stronger oversight of federal biosecurity programs.
"When individuals trusted with studying our most dangerous pathogens allegedly violate basic protocols, it undermines public confidence in our scientific institutions," Sanders said in a statement. The Congressional Progressive Caucus called for a review of NIH hiring practices for foreign nationals in sensitive research positions, arguing that background check procedures may need strengthening.
The American Public Health Association issued a statement emphasizing that the alleged conduct does not reflect broader concerns about scientific integrity but rather represents individual actions that must be addressed through proper legal channels. The organization noted that international collaboration remains essential for responding to global disease outbreaks.
What the Right Is Saying
Republican lawmakers seized on the charges as evidence of systemic failures in federal oversight of high-containment research facilities. House Oversight Committee Chairman James Comer of Kentucky announced plans for hearings examining NIH security protocols and whether adequate screening exists for foreign nationals employed at Biosafety Level 4 laboratories.
"This case raises serious questions about who we are allowing to handle dangerous pathogens on American soil," Comer said. "Congress must investigate how these individuals obtained positions at one of our highest-security facilities and what safeguards failed."
Senator Joni Ernst of Iowa, a member of the Senate Armed Services Committee, called for a comprehensive audit of all foreign nationals working in federal biosafety laboratories. Conservative commentators have argued that the incident demonstrates the risks of allowing foreign researchers access to dangerous biological materials without sufficient vetting.
FBI Detroit Special Agent in Charge Jennifer Runyan said the allegations involved "dangerous and unlawful smuggling" along with attempts to mislead federal agents. "No researchers should believe their positions, credentials, or professional status place them above the law," Runyan added.
What the Numbers Show
Monkeypox is a viral disease that spreads primarily through close physical contact with infected people, animals, or contaminated materials, according to the CDC. While most infected individuals recover, children, pregnant women, and people with weakened immune systems face greater risk of severe illness. The CDC states the virus does not spread through casual contact or airborne transmission in settings like classrooms, offices, or pools.
Monkeypox outbreaks have been ongoing in Central and Eastern Africa since late 2023. According to CDC data, the global clade IIb monkeypox outbreak that began in 2022 resulted in more than 100,000 cases across 122 countries.
Since November 2024, the United States has recorded more than 20 laboratory-confirmed clade I monkeypox cases, according to CDC surveillance data. Officials say those infections involved travelers returning from affected regions in Africa or Europe, or individuals linked to recent travelers. The clade I strain is considered more severe than the clade IIb variant that circulated globally during the 2022 outbreak.
Rocky Mountain Laboratories employs approximately 400 researchers and staff across multiple biosafety levels. Federal records indicate NIH spent $2.1 billion on biodefense research in fiscal year 2025, a figure that has remained relatively stable over the past five years despite periodic calls for budget reductions.
The Bottom Line
The case will proceed through federal courts in Michigan where prosecutors must prove the smuggling and false statement charges beyond a reasonable doubt. Both men remain presumed innocent until convicted.
Congressional scrutiny of NIH security practices is expected to intensify as Republicans on oversight committees launch investigations into hiring protocols for foreign nationals at high-containment facilities. The outcome could influence future legislation on biosecurity workforce requirements.
The case comes amid ongoing concerns about international disease surveillance cooperation, as the same scientific collaboration that enables global outbreak response also creates pathways for potential misuse of biological materials. Public health experts emphasize that legitimate international research partnerships remain essential while acknowledging the need for robust verification systems.